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Disulfide bond (DSB) formation is catalyzed by disulfide bond proteins and is critical for the proper folding
and functioning of secreted and membrane-associated bacterial proteins. Uropathogenic Escherichia coli
(UPEC) strains possess two paralogous disulfide bond systems: the well-characterized DsbAB system and the
recently described DsbLI system. In the DsbAB system, the highly oxidizing DsbA protein introduces disulfide
bonds into unfolded polypeptides by donating its redox-active disulfide and is in turn reoxidized by DsbB. DsbA
has broad substrate specificity and reacts readily with reduced unfolded proteins entering the periplasm. The
DsbLI system also comprises a functional redox pair; however, DsbL catalyzes the specific oxidative folding of
the large periplasmic enzyme arylsulfate sulfotransferase (ASST). In this study, we characterized the DsbLI
system of the prototypic UPEC strain CFT073 and examined the contributions of the DsbAB and DsbLI
systems to the production of functional flagella as well as type 1 and P fimbriae. The DsbLI system was able
to catalyze disulfide bond formation in several well-defined DsbA targets when provided in trans on a multicopy
plasmid. In a mouse urinary tract infection model, the isogenic dsbAB deletion mutant of CFT073 was severely
attenuated, while deletion of dsbLI or assT did not affect colonization.
Disulfide bonds bridging cysteine pairs impart structural sta-
bility and protease resistance to secreted and membrane-asso-
ciated proteins. Most organisms contain specific mechanisms
for the formation of disulfide bonds in proteins, a process
called oxidative protein folding. In bacteria, this folding pro-
cess is catalyzed by the disulfide bond family of proteins (18,
22). The best-characterized bacterial disulfide bond machinery
is the Escherichia coli K-12 oxidative system, which consists of
two enzymes, the periplasmic DsbA and the inner-membrane
DsbB (25, 35). DsbA is a monomeric protein comprising a
thioredoxin (TRX) domain with an embedded helical insertion
and a redox-active CPHC motif (34). This highly oxidizing
protein introduces disulfide bonds into unfolded polypeptides
by donating its redox-active disulfide (2, 4, 5), and as a result,
the two cysteines contained in the CPHC catalytic motif be-
come reduced. DsbB reoxidizes this cysteine pair and restores
the oxidizing activity of DsbA, enabling it to assist the folding
of a new substrate protein (21).
The DsbAB oxidative protein folding system plays a well-
documented part in bacterial virulence. Several studies have
demonstrated a direct role for both enzymes, particularly
DsbA, in the biogenesis of virulence factors utilized by bacte-
rial pathogens in various stages of the infection process (19).
The protein forming the P-ring of E. coli flagella, FlgI, was one
of the first DsbA substrates identified (10) and flagellum-me-
diated motility was subsequently demonstrated to require the
presence of functional DsbA in several gram-negative patho-
gens, including Salmonella enterica (1), Proteus mirabilis (8),
Erwinia carotovora subsp. atroseptica (9), Burkholderia cepacia
(17), and Campylobacter jejuni (42). In Yersinia pestis, S. en-
terica, Shigella flexneri, and enteropathogenic E. coli, deletion
of dsbA results in defective type III secretion, a major virulence
mechanism employed by these enteric pathogens to manipu-
late the host during infection. The defect was shown in each
case to involve the outer membrane secretin (YscC, SpiA,
Spa32, and EscC, respectively), which requires a single in-
tramolecular disulfide bond to adopt a functional conforma-
tion (23, 36, 37, 49). Fimbria-mediated adhesion is a crucial
first step of the infection process as it allows host colonization
by mucosal pathogens. DsbA is required for functional assem-
bly of several types of fimbriae, including P fimbriae of uro-
pathogenic E. coli (UPEC) (24), bundle-forming pili (Bfp) of
enteropathogenic E. coli (55), mannose-resistant Proteus-like
(MR/P) fimbriae of Proteus mirabilis (8), plasmid-encoded fim-
briae (Pef) of Salmonella enterica (6), type IV pili of Neisseria
meningitidis (47), and toxin-coregulated pili (Tcp) of Vibrio
cholerae (41). A number of studies have reported that dsbA
and/or dsbB mutants are attenuated in infection models (9, 16,
41, 48, 52).
The recent exponential increase in sequenced genomes has
offered a first glimpse at the diversity of disulfide bond systems
present in bacteria (13). In addition, it is now evident that
several bacterial species encode multiple DsbA paralogues,
often with demonstrated differences in substrate specificity.
Neisseria meningitidis, for example, encodes three DsbA oxi-
doreductases: two inner membrane-associated lipoproteins
(DsbA1 and DsbA2) and one periplasmic enzyme (DsbA3).
While redundancy was observed in the oxidative folding of
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virulence-associated proteins by DsbA1 and DsbA2, DsbA3
alone was unable to restore important meningococcal viru-
lence traits, such as type IV pilus-mediated adhesion to human
endothelial cells (47). Recently, a second E. coli disulfide bond
system (DsbLI) was identified in the genome-sequenced
UPEC strain CFT073 and was demonstrated to be a functional
paralogue of the prototypic DsbAB system (14). The oxi-
doreductase DsbL has the strongest oxidizing potential of all
DsbA homologues characterized to date. Although the crystal
structure of DsbL revealed a similar overall fold and domain
architecture to DsbA, DsbL contains a longer helical insertion
and deletions in the TRX domain that result in a truncated
peptide binding groove. Moreover, DsbL shows different sur-
face properties, including a distinct basic patch around the
active site, which was suggested to allow stricter substrate spec-
ificity than the highly hydrophobic surface surrounding the
active site of DsbA. Grimshaw and colleagues (14) demon-
strated the specificity of the DsbLI system for the periplasmic
enzyme arylsulfate sulfotransferase (ASST) encoded by assT, a
gene found immediately upstream of dsbL and dsbI on the
CFT073 chromosome. ASST belongs to a group of poorly
characterized large bacterial ASSTs that are proposed to me-
diate detoxification of phenolic substances by catalyzing the
transfer of sulfuryl groups from phenolic sulfates to phenol
(26–28, 30). A reason for the specificity of DsbLI for ASST
folding could be the presence of an allosteric disulfide bond,
recently revealed by the enzyme’s crystal structure (33). This
class of disulfide bond forms between C atoms of cysteines in
unusually close proximity (3.8 Å in the case of ASST) and has
higher steric strain energy than catalytic or structural disulfide
bonds, thus explaining the requirement for the stronger DsbL
oxidase for its formation (33). The activity of DsbL and DsbI
was studied using plasmids introduced into E. coli K-12 strains
with the native DsbAB system deleted. As yet, the role of the
DsbLI system in UPEC virulence has not been investigated.
E. coli CFT073 is a prototypic UPEC strain isolated from a
female patient with acute pyelonephritis (38). UPEC strains
are the causative agent of 80% of community-acquired uri-
nary tract infections (UTIs) and 30% of nosocomial infec-
tions (7). The uropathogenic lifestyle of UPEC CFT073 is
reflected in its genome, which contains several factors with an
established role in urovirulence, including the well-studied
type 1 and P fimbriae (50). Genomic comparison of CFT073—
and other recently sequenced UPEC strains—with E. coli
strains with distinct lifestyles (gut commensals, enteric patho-
gens, and avian pathogens) allows the discovery of genes
unique to genomes of uropathogenic bacteria that are poten-
tially novel urovirulence factors. One such UPEC-specific gene
is assT, the gene located upstream of dsbL and dsbI in the
chromosome of CFT073 (32).
Here we characterize the DsbLI system in its native genetic
background of UPEC CFT073 and compare and contrast the
contribution of each of the two paralogous disulfide bond
systems of CFT073 in the production of UPEC-associated vir-
ulence factors and in vivo uropathogenesis. Using isogenic
dsbAB and dsbLI deletion mutants of CFT073, we demonstrate
that the recently identified DsbLI oxidative protein folding
machinery of UPEC CFT073 plays a secondary role in the
production of urovirulence factors and does not appear to
contribute to virulence in the mouse infection model used in
this study. We also show that in the same infection model, an
isogenic assT deletion mutant of CFT073 is not attenuated.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. All strains and plasmids
used in this study are listed in Table 1. E. coli strains were routinely cultured at
37°C on solid or in liquid Luria-Bertani (LB) medium supplemented with kana-
mycin (50 g ml1) or ampicillin (100 g ml1). Culture media were supple-
mented with 1 mM isopropyl -D-1-thiogalactopyranoside (IPTG) to induce
expression of DsbA-DsbB and DsbL-DsbI from plasmids pDsbAB and pDsbLI,
respectively. All plasmid transformations into E. coli CFT073 (wild type and
deletion mutants) were carried out by electroporation. Plasmid pDsbAB was
generated by PCR amplification of dsbA (primers 1147 and 1148) and dsbB
(primers 1149 and 1150) genes from the chromosome of E. coli CFT073 and
subsequent cloning into EcoRI-HindIII of pUC19. Plasmid pDsbLI was gener-
ated by PCR amplification of dsbL-dsbI genes (primers 1145 and 1146) from the
chromosome of E. coli CFT073 and subsequent cloning into EcoRI-PstI of
pGEM-T Easy (Promega). In both vectors, expression of disulfide bond enzymes
was controlled by the inducible lac promoter. CFT073 mutants containing dele-
tions of dsb genes were constructed by -red-mediated homologous recombina-
tion as previously described (11) and confirmed by PCR and DNA sequencing.
The primers used are listed in Table S1 in the supplemental material.
DNA manipulation techniques. DNA techniques were performed as previously
described (44). Chromosomal DNA was purified using the GenomicPrep cell and
tissue DNA isolation kit (Amersham Pharmacia Biotech, Inc.). PCR was performed
using the Expand long template PCR system according to the manufacturer’s in-
structions (Roche, Australia). Oligonucleotides were purchased from Sigma, Aus-
tralia, and are listed in Table S1 in the supplemental material. DNA sequencing of
PCR products was performed using the BigDye Terminator v3.1 cycle sequencing kit
according to the manufacturer’s instructions (Applied Biosystems) and analyzed by
the Australian Equine Genome Research Centre, Brisbane, Australia.
Purification of DsbA and DsbL, production of polyclonal sera, and immuno-
blotting. The dsbA and dsbL genes were PCR amplified using primers containing
ligation-independent cloning extensions. The amplified genes were subsequently
inserted into a modified version of pET21a vector, which allows the introduction of
an N-terminal His6 tag followed by the tobacco etch virus protease cleavage site,
using ligation-independent cloning (12). Protein expression was carried out in
BL21(DE3)(pLysS) cells (Invitrogen) by autoinduction (45). Briefly, cells were
grown for 24 h at 30°C in minimal medium supplemented with 100 g ml1 ampi-
cillin and 34 g ml1chloramphenicol. After lysing the cells by sonication, cell debris
was removed and histidine-tagged proteins were purified using PrepEase Ni2
affinity resin (USB). Upon His6 tag cleavage with tobacco etch virus protease,
proteins were further purified by gel filtration chromatography on a Superdex S-75
column (GE Healthcare). Protein purity was then assessed by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis.
Polyclonal anti-DsbA and anti-DsbL sera were raised in rabbits by the Institute
of Medical and Veterinary Sciences (South Australia) following a standard
protocol (http://www.imvs.sa.gov.au/). For immunoblotting, whole-cell lysates or
purified protein samples were subjected to SDS-PAGE using NuPAGE Novex
10% Bis-Tris precast gels with NuPAGE MES (morpholineethanesulfonic acid)-
SDS running buffer (Invitrogen) and subsequently transferred to polyvinylidene
TABLE 1. E. coli strains and plasmids
E. coli strain or plasmid Relevant characteristic(s) Source orreference
Strains
CFT073 UPEC isolate (O6:K2:H1) 38
CFT073dsbAB CFT073dsbAdsbB::Km; Kmr This study
CFT073dsbLI CFT073dsbLI::Km; Kmr This study
CFT073dsbABdsbLI CFT073dsbAdsbB::Km
dsbLI; Kmr
This study
CFT073assT CFT073assT::Km; Kmr This study
Plasmids
pDsbAB dsbA and dsbB genes in
pUC19; Apr
This study
pDsbLI dsbL and dsbI genes in
pGEM-T Easy; Apr
This study
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difluoride microporous membrane filters using the iBlot dry blotting system as
described by the manufacturer (Invitrogen). Western blotting was performed
using rabbit polyclonal anti-DsbA or anti-DsbL primary sera (1/4,000 dilution)
followed by incubation with goat anti-rabbit immunoglobulin G-alkaline phos-
phatase-conjugated secondary antibody (1/10,000 dilution; Sigma). Signal devel-
opment was performed in BCIP/NBT (5-bromo-4-chloro-3-indolylphosphate–
nitroblue tetrazolium solution; Sigma).
Yeast cell and RBC agglutination. The expression of functional type 1 and P
fimbriae by E. coli CFT073 and isogenic dsb deletion mutants was investigated by
their ability to agglutinate yeast (Saccharomyces cerevisiae) cells and human red
blood cells (hRBCs), respectively. Agglutination was examined by mixing 10 l
of overnight E. coli culture with 10 l of 5% (wt/vol) yeast cell suspension (for
type 1 fimbriae) or 10% (vol/vol) type A hRBCs (for P fimbriae) in the presence
and absence of 1% (wt/vol) mannose. E. coli strains were considered positive
when visible clumping occurred within 3 min of mixing on a glass slide. All
experiments were performed in triplicate.
Motility assays. The motility of E. coli CFT073 and dsb deletion mutants was
assessed by inoculation of 2 l of overnight liquid culture onto the surface of
semisolid (0.25% [wt/vol]) agar. The diameter of bacterial outward growth was
recorded after 18 h of incubation at 37°C. Plasmid-complemented deletion mu-
tants were assessed in the presence and absence of 1 mM isopropyl--D-thioga-
lactopyranoside (IPTG). All experiments were performed in triplicate.
Mouse model of UTI. The mouse model of UTI was employed as previously
described (43). Briefly, female C57BL/6 mice (8 to 10 weeks) were purchased
from the University of Queensland Animal Facility and housed in sterile cages
with ad libitum access to sterile water. Preinoculation urine was examined mi-
croscopically and by culture, and animals with a combination of 5  102
CFU/ml and 2  105 leukocytes in urine were excluded. Mice were transure-
thrally catheterized with 	5  108 CFU (20 l bacterial phosphate-buffered
saline suspension) under isoflurane anesthesia. Mice were euthanized at 18 h
postinfection by cervical dislocation. Bacterial loads in urine and bladder ho-
mogenates of individual mice were determined by viable counts performed in
triplicate. Data are expressed as mean log CFU per ml of urine or 0.1 g of
bladder tissue 
 the standard error of the mean. A minimum of six mice were
included in each group. Equality of group medians of log-transformed data was
tested using the Kruskal-Wallis nonparametric test in the Minitab15 statistical
package. P values of 0.05 were considered significant.
RESULTS
Sequence comparison of DsbA and DsbL paralogues of E.
coli CFT073. The two genes of the prototypic DsbAB system
(dsbA and dsbB) are located at separate loci on the CFT073
chromosome (c4804 and c1633, respectively), while the dsbL
and dsbI genes lie adjacent to one another at a distinct chro-
mosomal location (c3786 and c3787). Despite sharing a similar
FIG. 1. (A) Structure-based sequence alignment of DsbA (Protein Data Bank no. 1FVK [15]) and DsbL (Protein Data Bank no. 3C7M [14])
using STRAP (http://www.charite.de/bioinf/strap/). Residues belonging to the TRX and helical domain are indicated by a gray bar and dark blue
bar, respectively. Identical residues are shown in red. Regions in DsbL that differ from DsbA are highlighted in boxes (the CXXC catalytic site
and the deletion at the C terminus that shortens the peptide binding groove) or underlined (positively charged residues in DsbL generate a basic
patch where DsbA has a hydrophobic patch). Arrows indicate the second cysteine in the CXXC motif and the conserved cis-proline, residues
utilized to measure the length of the inserted alpha-helical domain in the TRX fold. (B) Ribbon representations of E. coli K-12 DsbA (Protein
Data Bank no. 1FVK [15]) incorporating a TRX fold (gray) with a helical insertion (dark blue). The active-site disulfide is shown in a space-filling
representation (yellow). Arrows point at areas that differ between DsbA and DsbL (also highlighted in panel A). (C) Physical map demonstrating
the genomic location of the dsbL gene in selected genera from Gammaproteobacteria (pink box), Deltaproteobacteria (blue box), and Epsilonpro-
teobacteria (green box). Genes and intergenic regions are drawn to scale.
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overall fold and domain architecture (14), DsbA and DsbL
display low amino acid identity (Fig. 1A). Amino acid sequence
divergence, as well as insertions and deletions, is observed in
key regions of the protein, including the CXXC active site
(CPHC and CPFC in DsbA and DsbL, respectively), the hy-
drophobic area proximal to the active site, and the target
binding groove (positively charged in DsbL) (Fig. 1A and B).
As these differences are found in areas involved in substrate
recognition and binding, they may account for differences in
substrate specificity between DsbA and DsbL.
Prevalence and genomic organization of the dsbLI genes in
bacteria. In order to investigate the distribution of dsbL in
bacteria, we searched 404 complete bacterial genomes depos-
ited in the J. Craig Venter Institute public database (Compre-
hensive Microbial Resource) using the amino acid sequence of
DsbL from E. coli CFT073. Proteins with significant sequence
identity to DsbL (P  0.0002) were considered DsbL homo-
logues if (i) their sequence identity to DsbL was higher than
their sequence identity to DsbA from E. coli CFT073 and (ii)
they contained an identical active site to DsbL (CPFC) or if the
length of the inserted alpha-helical domain in the TRX fold
(counting from the catalytic CXXC domain to the conserved
cis-proline residue [Fig. 1A], which is present in most TRX-like
proteins) was118 residues (minimum insert length present in
CPFC-containing DsbL homologues). Using this set of criteria,
23 DsbL proteins were identified from 17 genomes of Gam-
maproteobacteria, Deltaproteobacteria, and Epsilonproteobacte-
ria of the following genera: Escherichia, Salmonella, Campy-
lobacter, Geobacter, and Shewanella (see Table S2 in the
supplemental material). Protein sequences satisfying the above
criteria were also identified in other Proteobacteria (Yersinia
frederiksenii, Enterobacter amnigenus, Klebsiella sp. strain K-36,
Citrobacter freundii, and Edwardsiella tarda) upon interrogation
of the NCBI database with the amino acid sequence of DsbL
from E. coli CFT073 (see Table S2 in the supplemental mate-
rial). The genomic location of dsbL was examined, and a dsbI
gene was present downstream of dsbL in all genomes (Fig. 1C;
and see Table S2 in the supplemental material). The genomes
of Campylobacter curvus, Campylobacter fetus, and Campy-
lobacter concisus contained a second copy of dsbL carried at a
different position on the chromosome without a dsbI gene in
close proximity, while the second copy of dsbL in the genome
of Camplobacter jejuni was carried immediately downstream of
dsbL, dsbI, and a degenerate copy of assT (Fig. 1C; and see
Table S2 in the supplemental material). The assT gene, encod-
ing the periplasmic substrate of DsbL in E. coli CFT073, was
colocated with the dsbL and dsbI genes in all but one genome
(Fig. 1C).
Construction and characterization of dsbA-dsbB and dsbL-
dsbI deletion mutants in E. coli CFT073. We employed -red-
mediated homologous recombination to delete the dsbA-dsbB
and dsbL-dsbI genes in E. coli CFT073. As the dsbA and dsbB
genes are located in different positions on the CFT073 chro-
mosome, deletion of these genes required two successive
rounds of mutagenesis. The CFT073 dsbA-dsbB deletion mu-
tant (CFT073dsbAB) was nonmotile (Fig. 2B). In contrast,
deletion of the dsbL-dsbI genes (CFT073dsbLI) did not affect
motility compared to that of wild-type CFT073 (Fig. 2C and
A). This suggested that either DsbL is not expressed at levels
sufficient to restore the loss of motility in the dsbA-dsbB mu-
tant or that FlgI—the flagella P-ring protein targeted by
DsbA—is not a substrate of DsbL.
The DsbAB and DsbLI systems can catalyze oxidative fold-
ing of the FlgI flagella P-ring protein. To compare the speci-
ficity of the DsbAB and DsbLI systems, we constructed a
dsbA-dsbB dsbL-dsbI double deletion mutant in E. coli CFT073
(CFT073dsbABdsbLI) and transiently expressed each disulfide
bond system in this genetic background. The lack of motility in
CFT073dsbABdsbLI (Fig. 2D) was restored upon complemen-
tation with both a dsbA-dsbB-carrying plasmid (pDsbAB) and
a dsbL-dsbI-carrying plasmid (pDsbLI) (Fig. 2E and F). Trans-
formation of CFT073dsbABdsbLI with the vector control did
not affect the motility phenotype (Fig. 1G and H). While
complementation with pDsbAB restored motility of CFT073
dsbABdsbLI to wild-type levels, pDsbLI restored only partial
motility. These results suggest that DsbL-DsbI can direct the
correct folding of FlgI in the absence of DsbA-DsbB when
expressed at high levels, albeit with reduced efficiency.
DsbA and DsbL expression in E. coli CFT073. The loss of
motility in CFT073dsbAB and the complementation by multi-
copy dsbL-dsbI suggest that DsbL might be expressed at low
levels in E. coli CFT073. To investigate whether both oxi-
doreductase paralogues are expressed in CFT073, we devel-
oped rabbit polyclonal antisera against DsbA and DsbL. The
specificity of each antiserum was checked using purified re-
combinant DsbA and DsbL, and no cross-reactivity was ob-
served (data not shown). A band of the correct size for DsbA
(	21 kDa) was observed in whole-cell lysates of CFT073
and CFT073dsbLI but was absent from CFT073dsbAB and
CFT073dsbABdsbLI (Fig. 3A). Complementation of CFT073
dsbABdsbLI with pDsbAB restored DsbA expression (Fig.
3A). No expression was detected for DsbL in CFT073 and all
three isogenic mutants under the conditions tested (Fig. 3B).
However, a band corresponding to DsbL was detected upon
complementation of CFT073dsbABdsbLI with pDsbLI (Fig.
3B). No DsbL expression was detected following growth of
CFT073 in human urine (data not shown).
Role of DsbA and DsbL in the production of P and type 1
fimbriae by E. coli CFT073. We investigated the contribution
of each disulfide bond system to the production of functional P
and type 1 fimbriae by testing the ability of CFT073 single and
double dsb deletion mutants to agglutinate hRBCs (indicative
of P fimbria expression) and yeast cells (indicative of type 1
FIG. 2. Motility analysis for wild-type CFT073 (A), CFT073dsbAB
(B), CFT073dsbLI (C), CFT073dsbABdsbLI (D), CFT073dsbABdsbLI
(pDsbAB) (E), CFT073dsbABdsbLI(pDsbLI) (F), CFT073dsbABdsbLI
(pUC19) (G), and CFT073dsbABdsbLI(pGEM-T Easy) (H).
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fimbria expression). The ability of CFT073 to cause hemagglu-
tination (HA) of hRBCs required the DsbAB but not the
DsbLI system (Table 2). However, a positive HA phenotype
was restored in CFT073dsbAB and CFT073dsbABdsbLI fol-
lowing complementation with either pDsbAB or pDsbLI (Ta-
ble 2). In contrast, mannose-sensitive yeast agglutination (YA)
was still observed with CFT073 deletion mutants for either or
both disulfide bond systems (Table 2). To investigate this fur-
ther, we measured the exact time required by each strain to
produce YA (Table 2). While CFT073dsbLI agglutinated yeast
cells as fast as wild-type CFT073, CFT073dsbAB displayed a
small (10 to 15 s) delay, which was partially restored upon
complementation of CFT073dsbAB and CFT073dsbABdsbLI
with either pDsbAB or pDbsLI. Taken together, these results
suggest that both disulfide bond systems can catalyze the bio-
genesis of functional P fimbriae in CFT073, with DsbAB pri-
marily contributing to the process, while functional assembly of
type 1 fimbriae can occur independently of both disulfide bond
systems.
Contribution of the DsbAB and DsbLI systems to coloniza-
tion of the mouse urinary tract. To study the role of both
disulfide bond systems in virulence, we examined the ability of
CFT073, CFT073dsbAB, and CFT073dsbLI to survive in the
mouse urinary tract. CFT073dsbAB was severely attenuated in
its ability to colonize the bladder (P  0.001) despite the fact
that it still produced type 1 fimbriae (Fig. 4A). Significantly
lower numbers of CFT073dsbAB cells were also recovered
from the urine of these mice compared to wild-type CFT073
(Fig. 4B). In contrast, no significant difference in the coloni-
zation of the bladder or urine was observed for CFT073dsbLI
compared to CFT073. No significant colonization of the kid-
neys was observed for any of the strains (data not shown); this
is consistent with previous data from our laboratory using
C57BL/6 mice.
Disruption of the assT gene does not affect colonization of
the mouse bladder. ASST, the periplasmic enzyme specifically
oxidized by DsbL, has been implicated as a virulence factor of
UPEC (32, 33). However, in our study CFT073dsbLI colonized
the mouse bladder at wild-type levels. To examine the possi-
bility that DsbA is responsible for functional ASST production
in the CFT073dsbLI mutant and to test whether ASST is re-
quired for UPEC virulence, we constructed an assT deletion
mutant in CFT073 (CFT073assT) and tested its ability to col-
onize the urinary tract of C57BL/6 mice. There was no signif-
icant difference in the abilities of CFT073 and CFT073assT to
colonize the mouse bladder following transurethral infection
(Fig. 4A). Similar numbers of each strain were also recovered
from the urine of infected mice (Fig. 4B); neither strain was
isolated from the mouse kidney (data not shown).
DISCUSSION
UPEC strains are successful extraintestinal pathogens
equipped with a mosaic genome encoding a plethora of factors
contributing to their uropathogenic lifestyle, such as surface
adhesins and secreted toxins. Membrane and secreted protein
folding in UPEC CFT073 is assisted by two distinct disulfide
catalytic systems, the prototypic DsbAB system also found in
E. coli K-12 and the recently identified DsbLI system. The
DsbAB system introduces disulfide bonds into unfolded
polypeptides in the periplasm and has broad substrate speci-
ficity. In contrast, the DsbLI system is proposed to be highly
FIG. 3. Western blot analysis of DsbA expression in wild-type
CFT073, CFT073dsbAB, CFT073dsbLI, CFT073dsbABdsbLI, and
CFT073dsbABdsbLI(pDsbAB) whole-cell lysates (A) and DsbL expression
in wild-type CFT073, CFT073dsbAB, CFT073dsbLI, CFT073dsbABdsbLI,
and CFT073dsbABdsbLI(pDsbLI) whole-cell lysates (B).
TABLE 2. Production of P and type 1 fimbriae by E. coli CFT073
and isogenic disulfide bond deletion mutants
E. coli strain HA(P fimbriae)
YA
(type 1
fimbriae)
Avg YA time
(s) 
 SD
CFT073   3 
 1
CFT073dsbLI   3.7 
 0.6
CFT073dsbAB   21.7 
 1.5
CFT073dsbAB(pDsbAB)   13.3 
 1.2
CFT073dsbAB(pUC19)   23 
 1.7
CFT073dsbAB(pDsbLI)   14.7 
 2.5
CFT073dsbAB(pGEM-T Easy)   19 
 2.6
CFT073dsbABdsbLI   17.7 
 3.1
CFT073dsbABdsbLI(pDsbAB)   7.3 
 0.6
CFT073dsbABdsbLI(pUC19)   18 
 1
CFT073dsbABdsbLI(pDsbLI)   7.7 
 0.6
CFT073dsbABdsbLI(pGEM-T
Easy)
  19 
 2.6
FIG. 4. Bacterial load in mouse bladders (A) and urine (B) 18 h
postinfection with CFT073, CFT073dsbAB, CFT073dsbLI, and
CFT073assT. The average log CFU per 0.1 g bladder or ml urine is
plotted 
 the standard error of the mean. *, P  0.05; **, P  0.001.
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specific for oxidizing the periplasmic enzyme ASST. Here we
demonstrated that when overexpressed, the DsbLI system can
catalyze disulfide bond formation in two targets of the DsbAB
system in E. coli CFT073: the flagellar motor component FlgI
and the P fimbrial chaperone PapD. Additionally, we con-
structed isogenic dsb mutants in CFT073 and assessed the
relative contribution of each disulfide bond system in UPEC
virulence by using a mouse UTI model.
Flagella-mediated motility is important for the dissemina-
tion of pathogenic bacteria in different niches within the host.
In the case of UPEC, this is required for bacterial ascent from
the bladder to the kidneys via the ureters against the flow of
urine (31). FlgI forms the P-ring of the flagellar structure
and P-ring assembly requires the introduction of a disulfide
bond by DsbAB in E. coli K-12 (10). The difference observed
in the ability of DsbLI and DsbAB to fully restore motility in
CFT073dsbABdsbLI in this study is most likely due to the
different biochemical properties of the two oxidases. This is
consistent with a previous study that examined DsbLI overex-
pression in an E. coli K-12 dsbA-dsbB deletion mutant (14).
An important first step in UPEC infection is adhesion to the
host mucosa. Adhesion mediated by P fimbriae has been ex-
tensively studied and shown to be required for the early estab-
lishment of UPEC in the human urinary tract (51). P fimbria
biogenesis follows the chaperone-usher pathway of protein
secretion, where the periplasmic chaperone PapD binds the
unfolded P fimbrial subunits emerging through the inner mem-
brane in a Sec-dependent manner and targets them to the
outer membrane usher PapC, which in turn directs their or-
dered assembly and secretion to the bacterial cell surface to
form the fimbrial fiber (46). PapD requires the formation of an
intramolecular disulfide bond in order to adopt its native con-
formation in vivo, and this allows it to interact with P fimbrial
subunit proteins (24). Overexpression of DsbL in the absence
of DsbA restored the production of functional P fimbriae in E.
coli CFT073dsbABdsbLI, demonstrating the capacity of DsbL
to catalyze disulfide bond formation in PapD. Other members
of the PapD-like chaperone superfamily have been described
from E. coli and other organisms (20, 40). For example, the
Caf1M chaperone of capsule in Yersinia pestis is the prototypic
member of the FGL subfamily of molecular chaperones and
contains two invariable cysteine residues that form a disulfide
bond in the subunit binding pocket (53, 54). Formation of this
disulfide bond is catalyzed by DsbA and is required for the
appropriate folding of Caf1M and for binding to the Caf1
capsule subunit of Y. pestis (53). Based on our results, it is
possible that DsbL may also be capable of catalyzing disulfide
bond formation in Caf1M and other members of the FGL
subfamily of chaperones.
In contrast to P fimbriae, the production of functional type
1 fimbriae (as measured by the ability to mediate yeast cell
agglutination) was not completely abolished in CFT073
dsbABdsbLI. This difference is most likely attributed to the
lack of cysteine residues in the FimC chaperone. These results
also suggest that disulfide bond formation within the major
(FimA) and minor (FimF, FimG, and FimH) components of
type 1 fimbriae can occur independently of DsbA and DsbL.
Our data are in agreement with a previous study which dem-
onstrated that removal of the cysteine bond in the mannose-
binding domain of FimH does not affect FimH-mannose bind-
ing under static or low-shear conditions (39). This is in contrast
to high-flow conditions, where FimH-mediated adhesion re-
quires the formation of a cysteine bond for the stabilization of
its mannose binding pocket.
Despite production of functional type 1 fimbriae (albeit at a
reduced level), deletion of the dsbAB system, but not the dsbLI
system, resulted in severe attenuation of E. coli CFT073 in a
mouse UTI model. This is likely due to a combined effect of
the dsbAB deletion on flagellum-mediated motility and the
production of P and type 1 fimbriae. Additionally, disruption of
the DsbAB system could have affected several other potential
targets among the 150 exported proteins that contain a cys-
teine pair in E. coli (13). Thus, the severe attenuation of
CFT073dsbAB may result from the cumulative contribution of
direct and pleiotropic effects. In this regard, we note that the
growth of CFT073dsbAB and CFT073dsbABdsbLI did not dif-
fer from wild-type CFT073 in LB broth and minimal media.
DsbLI is the proposed specialized oxidase system for the
periplasmic enzyme ASST (14). The genomic location of DsbL
homologues identified in this study supports this proposition,
as an assT gene is found in close proximity to dsbL and dsbI in
all but one of the examined genomes. The only exception is
Campylobacter concisus, where one of the two assT genes
present on the chromosome is located 17 genes apart from
dsbL and dsbI. In our bioinformatic search, we applied a series
of stringent cutoffs for the identification of DsbL homologues.
This resulted in the selection of less than 40 proteins distrib-
uted across 10 genera of Proteobacteria (see Table S2 in the
supplemental material). Our set of DsbL homologues was con-
gruent with the list of DsbL homologues identified in 33 assT-
containing genomes by Grimsahw et al. (14) and included
additional DsbL homologues from other Proteobacteria (Yer-
sinia, Citrobacter, Edwardsiella, Enterobacter, and Klebsiella). In
a recent comprehensive study of bacterial DsbA homologues
(19), we also identified CPFC-containing DsbA proteins in
Firmicutes (Listeria monocytogenes), Spirochaetes (Leptospira
interrogans and Leptospira innocua), and Actinobacteria (Acti-
nomyces naeslundii, Streptomyces coelicolor, Corynebacterium
glutamicum, and Mycobacterium sp.). However, these proteins
were not included in the current data set due to their low
sequence identity to DsbL (P  0.0002) and lack of biochem-
ical data confirming that they have similar redox properties
to DsbL.
In this study, we demonstrate functional redundancy be-
tween two paralogous oxidative protein folding systems from
E. coli CFT073 upon overexpression of DsbAB and DsbLI in
an isogenic double-dsb deletion mutant. Lack of DsbL expres-
sion in wild-type CFT073 could be due to the limited sensitivity
of detection by the Western blotting assay employed. Alterna-
tively, the optimal conditions for expression of the DsbLI sys-
tem were not reproduced in our experiments. In the chromo-
some of E. coli CFT073, the dsbL and dsbI genes lie
immediately downstream of the assT gene and the three genes
form a tricistronic operon (50). ASST is a large periplasmic
enzyme whose function is dependent upon the formation of a
single disulfide bond by the DsbLI dithiol oxidase system (14).
Therefore, it is likely that the DsbLI system is specifically
expressed under ASST-inducing conditions. ASST enzymes
have been characterized from various intestinal bacteria and
are proposed to function as detoxifying catalysts, converting
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toxic phenolic compounds and antibiotics into nontoxic sub-
stances (3, 26–30). Thus, although we were unable to demon-
strate a role for assT in colonization of the mouse urinary tract,
we cannot rule out the possibility that the precise conditions
required to activate assT expression were not reproduced in
this experiment. The precise environmental cues that regulate
assT gene expression remain to be elucidated.
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